Finversia.ru19 дн.
FDA одобрило препарат Amgen для лечения наиболее опасного вида рака легких
Управление по санитарному надзору за качеством пищевых продуктов и лекарственных препаратов (FDA) одобрило терапию Amgen для больных с ...
Drug Store News2 дн.
FDA approves Amgen's Soliris biosimilar
Amgen’s Bkemv is the first interchangeable biosimilar to Soliris to treat certain rare diseases. The treatment of patients ...
Pharmaceutical Technology8 дн.
FDA approves Amgen’s interchangeable biosimilar Bkemv
The US FDA has approved Amgen's Bkemv as an interchangeable biosimilar to Soliris for the treatment of specific rare diseases ...
US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment
The U.S. Food and Drug Administration approved on Tuesday Amgen's Bkemv, the first biosimilar to AstraZeneca's rare blood ...
Yahoo Finance20 дн.
FDA approves Amgen drug for tough-to-treat form of lung cancer
The Food and Drug Administration on Thursday granted accelerated approval to a new dual-acting drug from Amgen to treat small cell lung cancer in people whose disease has progressed following ...
BioPharma Dive20 дн.
FDA approves Amgen drug for tough-to-treat form of lung cancer
The Food and Drug Administration on Thursday granted accelerated approval to a new dual-acting drug from Amgen to treat small cell lung cancer in people whose disease has progressed following ...
rbc2 г. (лет)
FDA одобрило препарат компаний AstraZeneca и Amgen для лечения астмы
Управление по санитарному надзору за качеством пищевых продуктов и медикаментов (FDA) США одобрило препарат тезпир компаний AstraZeneca и Amgen для ...
ahajournals.org2 дн.
FDA Approves New Drug to Reduce Risk of Stroke
Originally published25 Jan 2000https://doi.org/10.1161/01.CIR.101.3.e41Circulation. 2000;101:e41 Anew drug to reduce the risk of stroke has received approval from the ...
Medical Xpress20 дн.
FDA approves new drug for deadly lung cancer
The U.S. Food and Drug Administration on Thursday approved a new drug to treat patients with an advanced form of deadly lung cancer. Importantly, tarlatamab (Imdelltra) is only for patients who ...
healthday20 дн.
FDA Approves New Drug for Deadly Lung Cancer
FRIDAY, May, 17, 2024 (HealthDay News) -- The U.S. Food and Drug Administration on Thursday approved a new drug to treat patients with an advanced form of deadly lung cancer. Importantly, tarlatamab ...